In Silico Preclinical Trials: Methodology and Engineering Guide to Closed-Loop Control in Type 1 Diabetes Mellitus
Доклинические испытания in silico: методология и инженерное руководство по управлению с обратной связью при сахарном диабете 1 типа
2009-03-01
SCID: 54.1/c9kct65v
Discuss with AI
artificial pancreas control algorithmsclosed-loop controlglucose-insulin systemin silico preclinical trialstype 1 diabetes mellitus
Figures from the paper
Abstract (AI)
This article sets forth guidelines for in silico (simulation-based) proof-of-concept testing of artificial pancreas control algorithms. The goal was to design a test procedure that can facilitate regulatory approval [e.g., Food and Drug Administration Investigational Device Exemption] for General Clinical Research Center experiments without preliminary testing on animals. The methodology is designed around a software package, based on a recent meal simulation model of the glucose-insulin system. Putting a premium on generality, this document starts by specifying a generic, rather abstract, meta-algorithm for control. The meta-algorithm has two main components: (1) patient assessment and tuning of control parameters, i.e., algorithmic processes for collection and processing patient data prior to closed-loop operation, and (2) controller warm-up and run-time operation, i.e., algorithmic processes for initializing controller states and managing blood glucose. The simulation-based testing methodology is designed to reveal the conceptual/mathematical operation of both main components, as applied to a large population of in silico patients with type 1 diabetes mellitus.
Key Findings
1
A software package implementing a recent meal simulation model of the glucose–insulin system underpins the testing procedure.
2
Testing across a large simulated population is designed to expose the conceptual and mathematical operation of both control components.
3
The article provides guidelines for simulation-based proof-of-concept testing of artificial pancreas control algorithms.
4
The methodology aims to support regulatory approval for clinical research experiments without preliminary animal testing.
5
The proposed meta-algorithm separates patient-specific assessment and parameter tuning from controller warm-up and runtime blood-glucose management.
Research Object
Artificial pancreas closed-loop control for blood glucose management in in silico patients with type 1 diabetes mellitus
Research Subject
Simulation-based evaluation of patient assessment and controller tuning, initialization, and run-time operation across a large virtual patient population to characterize the conceptual and mathematical behavior of control algorithms
Publication Details
Publication Date
2009-03-01
Journal
Journal of Diabetes Science and Technology
Publisher
SAGE Publishing
ISSN
1932-2968
Cited by
92
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai5
Meal Simulation Model of the Glucose-Insulin System2007
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes2009
Model Predictive Control of Type 1 Diabetes: An in Silico Trial2007
GIM, Simulation Software of Meal Glucose—Insulin Model2007
Safety Constraints in an Artificial Pancreatic β Cell: An Implementation of Model Predictive Control with Insulin on Board2009
Cited by5
Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes2010
A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator2009
Immune-evasive beta cells in type 1 diabetes: innovations in genetic engineering, biomaterials, and computational modeling2025
An Artificial Pancreas for Automated Blood Glucose Control in Patients With Type 1 Diabetes2015
Deep Reinforcement Learning Control of Type-1 Diabetes with Cross-Patient Generalization2024